Citation Impact
Citing Papers
For debate: pet birds as an independent risk factor for lung cancer.
1988
Challenges in the Treatment of Chronic Wounds
2015 Standout
North of England evidence based guidelines development project: summary version of evidence based guideline for the primary care management of asthma in adults: Fig 1
1996
Death from Bronchial Asthma
1988 Standout
Combined corticosteroid and long-acting beta 2 -agonist in one inhaler versus placebo for chronic obstructive pulmonary disease
2013
IL-17A-Expressing T Cells Are Essential for Bacterial Clearance in a Murine Model of Hypersensitivity Pneumonitis
2009
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
2012 Standout
British Thoracic Society guideline for diagnostic flexible bronchoscopy in adults: accredited by NICE
2013 Standout
Acute Biological Effects of Simulating the Whole-Body Radiation Dose Distribution from a Solar Particle Event Using a Porcine Model
2011 StandoutNobel
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2007 Standout
Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial
2003
Early onset of effect of salmeterol and fluticasone propionate in chronic obstructive pulmonary disease
2005
Gene-environment interactions in sarcoidosis: challenge and opportunity
2007
Health complaints and immunological markers of exposure to bioaerosols among biowaste collectors and compost workers
2000
A comparison of the efficacy and safety of inhaled corticosteroids in asthma
1997
Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel
2000 Standout
Beneficial effects of nicotine and cigarette smoking: the real, the possible and the spurious
1996
Relationships Between Authors of Clinical Practice Guidelines and the Pharmaceutical Industry
2002 Standout
Novel Oral Drug Formulations
1994
Use of Spirometry for Case Finding, Diagnosis, and Management of Chronic Obstructive Pulmonary Disease (COPD): Evidence Report/Technology Assessment, Number 121
2005
Recommendations for the prevention and treatment of glucocorticoid‐induced osteoporosis
1996
Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease
1998
The European Community Respiratory Health Survey
1994 Standout
Psychometric evaluation of the pittsburgh sleep quality index
1998 Standout
Effectiveness and tolerability of high‐dose salmeterol in cystic fibrosis
2002
Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease
2005 Standout
Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD
2004
Hypersensitivity pneumonitis and antigen identification – An alternate approach
2015
Positron Emission Tomography Demonstrates Radiation-Induced Changes to Nonirradiated Lungs in Lung Cancer Patients Treated With Radiation and Chemotherapy
2005
Respiratory Arrest in near-Fatal Asthma
1991 Standout
The diverse potential effector and immunoregulatory roles of mast cells in allergic disease
2000
Network meta-analysis on the log-hazard scale, combining count and hazard ratio statistics accounting for multi-arm trials: A tutorial
2010
A 6-Month, Placebo-Controlled Study Comparing Lung Function and Health Status Changes in COPD Patients Treated With Tiotropium or Salmeterol
2002
Treatment of Nocturnal Asthma by Addition of Oral Slow-Release Albuterol to Standard Treatment in Stable Asthma Patients
1996
Impact of preventing exacerbations on deterioration of health status in COPD
2004 Standout
Multi-Ethnic Study of Atherosclerosis: Objectives and Design
2002 Standout
Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease
2003
Bird Fancier's Lung
2008
Interstitial lung disease guideline
2008
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
Prevalence of occupational asthma due to latex among hospital personnel.
1995 Standout
Long-term treatment of chronic obstructive pulmonary disease with salmeterol and the additive effect of ipratropium
2000
Chronic Obstructive Pulmonary Disease
2000
Efficacy and safety of oxitropium bromide, theophylline and their combination in COPD patients: a double-blind, randomized, multicentre study (BREATH Trial)
2002
Development and first validation of the COPD Assessment Test
2009 Standout
The Diagnosis, Assessment and Treatment of Diffuse Parenchymal Lung Disease in Adults
1999
A review of waste management practices and their impact on human health
2009 Standout
Idiopathic pulmonary fibrosis
2017 Standout
Inhaled and nasal corticosteroids: safety aspects*
2000
Designing hydrogels for controlled drug delivery
2016 Standout
Global strategy for asthma management and prevention: GINA executive summary
2007 Standout
Pharmacologic Interventions in Chronic Obstructive Pulmonary Disease: Bronchodilators
2007
Periodontal diseases
2017 Standout
Periodontal diseases
2005 Standout
Mortality in Mexican Patients with Chronic Pigeon Breeder's Lung Compared with Those with Usual Interstitial Pneumonia
1993
Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
2007 Standout
Efficacy of Salmeterol Xinafoate in the Treatment of COPD
1999
Sarcoidosis
2007 Standout
Increase in non‐specific bronchial responsiveness after repeated inhalation of low doses of allergen
1993
Chronic hypersensitivity pneumonitis in Japan: A nationwide epidemiologic survey
1999
Salmeterol Plus Theophylline Combination Therapy in the Treatment of COPD
2001
Cardiovascular Safety of Salmeterol in COPDa
2003
Mast cells in the development of adaptive immune responses
2005 Standout
Onset of action of aqueous beclomethasone dipropionate nasal spray in seasonal allergic rhinitis
1995
Late-phase IgE-mediated reactions
1988
Fruit, vegetables, and cancer prevention: A review of the epidemiological evidence
1992 Standout
A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary Disease
2008 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2001 Standout
An Official American Thoracic Society Clinical Practice Guideline: The Clinical Utility of Bronchoalveolar Lavage Cellular Analysis in Interstitial Lung Disease
2012 Standout
Walking versus Cycling
2005
Inhaled Formoterol Dry Powder Versus Ipratropium Bromide in Chronic Obstructive Pulmonary Disease
2001
Brain Natriuretic Peptide and Exercise Capacity in Lung Fibrosis and Pulmonary Hypertension
2004
An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases
2007 Standout
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
2003 Standout
American Thoracic Society Statement
2003 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Pulmonary rehabilitation for chronic obstructive pulmonary disease
2015 Standout
Immunopathogenesis of hypersensitivity pneumonitis
1977
Impact of Tobacco Use on Periodontal Status
2001
Bioaerosol Health Effects and Exposure Assessment: Progress and Prospects
2003 Standout
Hot Tub Associated Granulomatous Lung Disease From Mycobacterial Bioaerosols
2008
Enhancement of cardiotoxic effects of β-adrenergic bronchodilators by aminophylline in experimental animals
1981
The medically important aerobic actinomycetes: epidemiology and microbiology
1994 Standout
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
2015 Standout
Immune and inflammatory function in cigarette smokers.
1987
Idiopathic Pulmonary Fibrosis: Prevailing and Evolving Hypotheses about Its Pathogenesis and Implications for Therapy
2001 Standout
The COPDX Plan: Australian and New Zealand Guidelines for the management of Chronic Obstructive Pulmonary Disease 2003
2003 Standout
γδ T cells protect against lung fibrosis via IL-22
2010
Canadian Thoracic Society Recommendations for Management of Chronic Obstructive Pulmonary Disease – 2007 Update
2007
The Effects of Plant Flavonoids on Mammalian Cells:Implications for Inflammation, Heart Disease, and Cancer
2000 Standout
The effect of disodium cromoglycate in perennial rhinitis
1972
Epidemiology of uterine fibroids: a systematic review
2017 Standout
Use of Inhaled Corticosteroids and Risk of Fractures
2001 Standout
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
2009 Standout
Mast Cells Can Amplify Airway Reactivity and Features of Chronic Inflammation in an Asthma Model in Mice
2000
Value of theophylline treatment in patients handicapped by chronic obstructive lung disease.
1993
Primary biological aerosol particles in the atmosphere: a review
2012 Standout
The effect of autologous bone marrow-derived cells on healing chronic lower extremity wounds: results of a randomized controlled study.
2011
Th17-Polarized Immune Response in a Murine Model of Hypersensitivity Pneumonitis and Lung Fibrosis
2009
Maternal smoking influences cord serum IgE and IgD levels and increases the risk for subsequent infant allergy
1986
Smoking and Periodontal Disease
2000
Response to Bronchodilators
1989
Integrating mechanisms of pulmonary fibrosis
2011 Standout
Works of G. Boyd being referenced
Quantifying serum antibody in bird fanciers' hypersensitivity pneumonitis
2006
Effect of inhaled corticosteroids on bone
1994
Chronic Simple Bronchitis in Pigeon Fanciers
1989
Clearance of 99m Tc-DTPA in Pigeon Fancier's Hypersensitivity Pneumonitis
1990
Extrinsic allergic alveolitis
2006
Hypersensitivity pneumonitis: current concepts
2001
Obstructive airways disease in non‐smoking subjects with pigeon fanciers' lung
1989
Effect of cigarette smoking on the specific antibody response in pigeon fanciers.
1988
Longitudinal course of extrinsic allergic alveolitis in pigeon breeders.
1989
The quantitation of antibody in farmer's lung syndrome using a radioimmunoassay. Results of a clinical survey and comparison of three serological methods.
1975
An evaluation of salmeterol in the treatment of chronic obstructive pulmonary disease (COPD)
1997
Clinical and pharmacological study of a novel controlled release preparation of salbutamol.
1990
Effect of cigarette smoking on the antibody response to inhaled antigens and the prevalence of extrinsic allergic alveolitis among pigeon breeders
1985
Antibody measurement in extrinsic allergic alveolitis.
1984
Combination of aminophylline (Phyllocontin Continus tablets) and salbutamol in the management of chronic obstructive airways disease.
1980
Site of airflow obstruction in immediate and late reactions to bronchial challenge with Dermatophagoides pteronyssinum
1983
Beclomethasone dipropionate in seasonal allergic rhinitis. A comparison of two preparations.
1985
Antibody against a pigeon bloom‐extract: a further antigen in pigeon fanciers' lung
1982
DISODIUM CROMOGLYCATE IN THE TREATMENT OF ALLERGIC BRONCHIAL ASTHMA
1968
Factors influencing the occurrence of a late reaction to allergen challenge in atopic asthmatics
1984
Prevention of non-healing wounds through the prediction of chronicity
2004
Use of Radiolabelled Antiglobulin for Quantitation of Antibody to Soluble Antigens Rendered Particulate: Application to Human Sera from ‘Pigeon Fancier’s Lung Syndrome’
1974
Skin testing and extrinsic allergic alveolitis.
1983
Climate, intermittent humidification, and humidifier fever.
1989
Twice or four times daily beclomethasone dipropionate in mild stable asthma?
1985